semaglutide soul trial: Oral demonstrates a 14% reduction in risk of major adverse CV events SOUL Trial (NEJM 2025): Oral

Public comments on the MCL petition are due by August 29, 2025

Our testers experience Our tester approached their first appointment with some trepidation

Facile synthesis of a biocompatible silver nanoparticle derived tripeptide supramolecular hydrogel for antibacterial wound dressings

IV fluids deliver hydration, vitamins, and medications directly into your bloodstream, allowing for faster absorption and quicker relief

It represents a key mechanism by which hepatocytes eliminate excess triglycerides, independent of the traditional cytosolic lipase-mediated hydrolysis pathway

Industry analysts estimated that Pfizer retained approximately 70% of the economics from Watsons AG sales through the licensing arrangement